Innovation Forum 2022: Presentation of the HoloGRAFT cfDNA monitoring kit

The new HoloGRAFT cfDNA dPCR monitoring kit, designed for the quantification of tiny amounts of cell-free DNA, serving as a biomarker of organ health in patients after solid organ transplantation, has been presented during the first-ever Innovation Forum virtual event. This webinar, organized by QIAGEN, focuses on the latest innovations in life sciences and offers exciting talks by expert scientists, among others on personalized cancer care, antibiotic resistance, mRNA vaccines or novel drug targets.

The HoloGRAFT cfDNA dPCR monitoring kit presentation, given by JETA Molecular´s CEO Doug Bost, is available following this link:

https://www.qiagen.com/us/knowledge-and-support/knowledge-hub/events-and-webinars/webinars/innovation-forum/c-e-2-bost